The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1/2 study of AU-007, a monoclonal antibody (mAb) that binds to IL-2 and inhibits CD25 binding, in patients with advanced solid tumors: Interim results.
 
Sophia Frentzas
Consulting or Advisory Role - GOG Foundation; MSD Oncology
 
Elizabeth Stephanie Ahern
Honoraria - MSD Oncology
Research Funding - Amgen (Inst)
Patents, Royalties, Other Intellectual Property - U.S. Provisional Application No. 62/775803
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb
 
Andrew James Weickhardt
Honoraria - Eisai; Merck Sharp & Dohme
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer
Speakers' Bureau - Astellas Pharma
Research Funding - Merck
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen; Merck Sharp & Dohme
 
Andrew Mark Haydon
Honoraria - Merck; Novartis; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis
Speakers' Bureau - Bristol-Myers Squibb; Merck; Novartis
Expert Testimony - BMS
 
Paul L. de Souza
Stock and Other Ownership Interests - Filamon Pty
Consulting or Advisory Role - Biosceptre International; Harbour BioMed
 
John D. Powderly
Employment - BioCytics; Carolina BioOncology Institute
Leadership - BioCytics; Carolina BioOncology Institute
Stock and Other Ownership Interests - BioCytics; Carolina BioOncology Institute
Consulting or Advisory Role - Aavocyte; Abbvie; AstraZeneca/MedImmune; Boxer Capital; Genentech/Roche; Phanes Therapeutics; TERUMO; TopAlliance BioSciences Inc
Research Funding - Abbvie; Adagene (Inst); Alkermes; Apros Therapeutics; Arcus Biosciences; Ascendis Pharma (Inst); AstraZeneca/MedImmune; Atreca (Inst); BioBank Online (Inst); BJ Bioscience (Inst); Bristol-Myers Squibb; Calico; CEM Corporation (Inst); Conjupro Biotherapeutics (Inst); Corvus Pharmaceuticals; Cullinan Oncology (Inst); Curis; EMD Serono; Engineered BioPharmaceuticals (Inst); Fate Therapeutics (Inst); FLX Bio; Function Oncology (Inst); Genentech/Roche; I-Mab (Inst); Immune-Onc Therapeutics (Inst); Incyte; Jounce Therapeutics; Lilly/ImClone; Macrogenics; Merck (Inst); Molecular Templates (Inst); MT Group (Inst); NextCure (Inst); Nuvation Bio (Inst); Pioma Chemicals (Inst); Precision for Medicine (Inst); Repertoire Immune Medicines (Inst); Replimune (Inst); Seagen; Sequenom (Inst); STEMCELL Technologies (Inst); Tempest Therapeutics; Therapeutic BrainPower LLC (Inst); Top Alliance BioScience; Trethera (Inst); Xilio Therapeutics (Inst); Xilis (Inst); Zenshine (Inst)
Patents, Royalties, Other Intellectual Property - BioCytics is developing intellectual property for cellular immunotherapy
 
Timothy Wyant
Employment - Abpro; Aulos Bioscience; Biolojic; Curis
Leadership - Aulos Bioscience; Biolojic
Stock and Other Ownership Interests - Aulos Bioscience; Biolojic
Patents, Royalties, Other Intellectual Property - WO/219 087292 A1, US-20200289477-A1 Conjoint therapies for Immunomodulation. 2019 Sasikumar; Pottayil Govindan N. et al.; WO2022003690A3 Anti-tumor necrosis factor receptor (tnfr2) antibodies and uses thereof
Travel, Accommodations, Expenses - Biolojic
 
Jenny Tang
Employment - Aulos Bioscience
Stock and Other Ownership Interests - Aulos Bioscience
 
Lori Richards
Employment - Aulos Bioscience
Stock and Other Ownership Interests - Aulos Bioscience
 
Aron Knickerbocker
Employment - Aulos Bioscience
Leadership - Aulos Bioscience; KAHR Medical; Phenomic AI
Stock and Other Ownership Interests - Aulos Bioscience; KAHR Medical; Phenomic AI; RayzeBio
 
Inbar Amit
Employment - Biolojic
Stock and Other Ownership Interests - Biolojic
Patents, Royalties, Other Intellectual Property - Biologic Design
 
Yanay Ofran
Employment - Biolojic
Leadership - Aulos Bioscience; Biolojic; Ukko
Stock and Other Ownership Interests - Aulos Bioscience; Biolojic; Ukko
Consulting or Advisory Role - Aulos Bioscience; Biolojic; Ukko
Patents, Royalties, Other Intellectual Property - Aulos Bioscience; Biolojic; Ukko
 
James Robert Vasselli
Employment - Aulos Bioscience
Leadership - Aulos Bioscience
Stock and Other Ownership Interests - Aulos Bioscience